With diabetes, COVID-19 raises specific worries for patients

  • Joensen LE & al.
  • Diabet Med
  • 11 may. 2020

  • de Miriam Tucker
  • Clinical Essentials
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

Takeaway

  • Patients with diabetes have high prevalence of diabetes-specific worries during the COVID-19 pandemic.

Why this matters

  • Little is known about how worldwide pandemics affect psychosocial health of people with diabetes.

Study design

  • Cross-sectional survey via online questionnaire completed by 1396 adults with diabetes (34.6% type 1; 61.6% type 2; 3.8% other).   
  • Funding: None disclosed.

Key results

  • The most frequent worries:
    • Being overly affected by COVID-19 because of diabetes: 56%. 
    • Being characterized as an at-risk group: 39%.
    • Inability to manage diabetes with COVID-19: 28%. 
    • Reduced access to diabetes medications (24%) or equipment (17%).
  • Worry about being overly affected was greater (ORs; 95% CIs) among:
    • Women vs men: 1.6 (1.3-2.1); and 
    • Those with moderate-high distress levels: 4.9 (3.2-7.5).
    • It was lower with type 2 vs type 1 diabetes: 0.6 (0.5-0.8).
  • Worry about being unable to manage diabetes with COVID-19 was greater among:
    • Women: 1.7 (1.3-2.1); and
    • Those with diabetes complications: 1.4 (1.2-1.8).
  • Individuals with worries:
    • Checked blood glucose more often: 1.6-1.7 (1.0-2.6);
    • Were more aware of medication taking: 2.3-3.0 (1.3-4.9); and 
    • Exercised more than usual: 1.3-1.7 (1.0-2.2).

Limitations

  • Convenience sample, may be healthier than average.
  • Self-reports.